Personalized Therapy: Immunoglobulin Replacement for Antibody Deficiency.
Copyright policy )Personalized Therapy: Immunoglobulin Replacement for Antibody Deficiency.
Immunoglobulin replacement therapy is the cornerstone of management for most primary immunodeficiency disease patients. The selection of a particular product, dose, and route of administration requires an understanding of the features of therapeutic immunoglobulin as well as patient-specific risk factors in order to maximize efficacy and tolerability and minimize risk. Individualizing therapy, taking into consideration the burdens of care, is necessary in order to optimize patient outcomes.
Drug Administration Routes, Clinical Decision-Making, Immunization, Passive, Disease Management, Immunoglobulins, Intravenous, Health Services Accessibility, Treatment Outcome, Cost of Illness, Agammaglobulinemia, Immunoglobulin G, Animals, Humans, Precision Medicine
Drug Administration Routes, Clinical Decision-Making, Immunization, Passive, Disease Management, Immunoglobulins, Intravenous, Health Services Accessibility, Treatment Outcome, Cost of Illness, Agammaglobulinemia, Immunoglobulin G, Animals, Humans, Precision Medicine
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).26 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!